35571 |
Oncology |
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-La... |
TARGET ONCOL 2020 10.1007/s11523-020-00706-0 |
박세훈 |
2020 |
35570 |
Oncology |
Tumor Mutational Burden Determined by Panel Sequencing Predicts Surviv... |
Front Oncol 2020 10.3389/fonc.2020.00314 |
박세훈 |
2020 |
35569 |
Pathology |
TPK1 as a predictive marker for the anti-tumour effects of simvastatin... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152820 |
박세훈 |
2020 |
35568 |
Oncology |
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant... |
J CLIN ONCOL 2020 10.1200/JCO.19.01638 |
박세훈 |
2020 |
35567 |
Oncology |
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes ... |
CANCERS 2020 10.3390/cancers12040943 |
박세훈 |
2020 |
35566 |
Pathology |
High PD-L1 expression in gastric cancer (GC) patients and correlation ... |
PATHOL RES PRACT 2020 10.1016/j.prp.2020.152881 |
박세훈 |
2020 |
35565 |
Oncology |
First-in-human phase I trial of anti-hepatocyte growth factor antibody... |
THER ADV MED ONCOL 2020 10.1177/1758835920926796 |
박세훈 |
2020 |
35564 |
Medicine, General & Internal |
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on S... |
JAMA-J AM MED ASSOC 2020 10.1001/jama.2020.1707 |
박세훈 |
2020 |
35563 |
Oncology |
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gas... |
J ONCOL 2020 10.1155/2020/4659062 |
박세훈 |
2020 |
35562 |
Genetics & Heredity |
Comprehensive pharmacogenomic characterization of gastric cancer |
Genome Med 2020 10.1186/s13073-020-0717-8 |
박세훈 |
2020 |